Home » Newsletters » BioWorld

BioWorld

March 30, 1994

View Archived Issues

CORTECS, BOEHRINGER TO TEST H. PYLORI IMMUNOASSAY

ALFACELL CORP. RAISES $2M IN PRIVATE PLACEMENT

DNA SHOWS AND TELLS BIRDS RELATE MORE TO REPTILES THAN TO MAMMALS

HYERGAM+CF ENTERS TRIALS

GENE THERAPY TESTED AGAINST HIV AT UCSD

ENDOGEN MOVES TO CAMBRIDGE

BRITISH BIO-TECHNOLOGY GROUP RAISES $70M

MILLENNIUM, ROCHE SET TO INK $70M DEAL

THE HUMAN GENOME THERAPEUTIC BATTLEFIELD OF THE 21ST CENTURY

Popular Stories

Today's news in brief
BioWorld
ADPD 2026: Can we prevent dementia? Scientists quantify it
BioWorld
Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...
ADPD 2026: Three inflection points to target Alzheimer’s disease
BioWorld Science
A new way of understanding Alzheimer’s disease, based on biological inflection points that mark decisive moments in the progression of the disorder, could change...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 17, 2026
SERCA inhibitor from Sumitomo shows promise for MSA-C treatment
BioWorld Science
At the ongoing International Conference on Alzheimer’s and Parkinson’s Diseases and Related Neurological Disorders (AD/PD 2026) in Copenhagen, Sumitomo Pharma Co....